Abstract of Grant No. 5R01AI30628-02, "Prevention of perinatal group B streptococcal infections (human, mice, rabbits)", Kasper D.L., Principal Investigator, Dialog File 265/266, Fed. Research in Progress, printout of Jan. 26, 1993 for fiscal year 1992. |
Abstract of Grant No. 2R37A23339-08, "Immunochemistry of Group B Streptococcus polysaccharides (human, mice, rabbits)", Kasper, D.L., Principal Investigator, Dialog File 265/266, Fed. Research in Progress, printout of Jan. 26, 1993 for fiscal year 1992. |
Attachment A (Work Statement) form Request for Proposal No. NIH-NIAID-DMID-92-13, issued by the Department of Health and Human Services for the National Institutes of Health on Jan. 21, 1992, entitled, "Prevention of Group B Streptococcal Infections in Neonatal and Infant Populations". |
Baker et al., New Engl. J. Med., 319 18:1180-1185, 1988. |
Baker et al., Reviews of Infectious Diseases 7(4):458-467, 1985. |
Baker, C.J., "Immunization to Prevent Group B Streptococcal Disease: Victories and Vexations", Journal of Infectious Disease, vol. 161, No. 5, pp. 917-921, May 1990. |
Bittle, J.L., et al. "Vaccines Produced by Conventional Means to Control Major Infectious Diseases of Man and Animals", Adv. Vet. Sci. Comp. Med., vol. 33, pp. 1-63, Feb. 1989. |
Boyer et al., Clinical Research 34(4):962A, 1986. |
Coleman, R.T., et al. "Prevention of Neonatal Group B Streptococcal Infections: Advances in Maternal Vaccine Development", Obst. Gynec., vol. 80, No. 2, pp. 301-309, Aug. 1992. |
Devi, et al. "Antibodies to poly[(2.fwdarw.8)-.alpha.-N-acetylneuraminic acid] and poly[2.fwdarw.9)-.alpha.-N-acetylneuraminic acid] are elicited by immunization of mice with Escherichia coli K92 conjugates: potential vaccines for groups B and C meningococci and E. coli K1", Proc. Natl. Acad. Sci. USA, vol. 88, Aug. 1991, pp. 7175-7179. |
Dick and Beurret (1989) "Glyconjugates of Bacterial Carbohydrate Antigens--A Survey and Consideration of Design and Preparation Factors" Conjugate Vaccines) In Contrib. Microbiol. Immunol. (Cruse, JM and Lewis, RE. Tr. (eds.) Basel Karger Vol. 10:48:114. |
Dintzis, "Rational Design of Conjugate Vaccines", Pediatric Research, vol. 32, No. 4, pp. 376-385, Oct. 1992. |
Facklam et al., "Streptucocci and Aerocucci" in Manual of Clinical Microbiology, Lenette et al. eds. American Society for Microbiol. Wash., D.C. 1985, p. 154-175. |
Feldman, et al. "The immune response to the group B streptococcus", Reviews in Medical Microbiology, vol. 3, No. 1, Jan. 1992, pp. 52-58. |
Givner, et al. "Pooled Human IgH hyperimmune for type III Group B Streptococci: Evaluation against multiple strains in vitro and in experimental diseases", J. Infectious Diseases, vol. 163, pp. 1141-1145, May 1991. |
Heiman, et al. "The Opsonic Antibody Response of Female Rats to Type III Group B Streptococcal Immunization: a Model for Maternal Immunity", Veterinary Immunology and Immunopathy, vol. 24, 1990, pp. 79-89. |
Insel, R.A., "Maternal Immunization of Prevent Neonatal Infections", New England Journal of Medicine, vol. 319, No. 18, pp. 1219-1220, Nov. 1988. |
Jennings and Lugowski, "Immunochemistry of Groups A, B and C Meningococcal Polysaccharide Tetanus Toxoid Conjugates", The Journal of Immunology, 127:1011-1017 (1981). |
Jennings, (1983) "Capsular Polysaccharrides as Human Vaccines" In Advances Carbohydrate Chemistry and Biochemistry, vol. 41:155-207. Academic Press, Inc., NY, NY. |
Jennings, et al. (1982) "Structural Determination of the Capsular Polysaccharide Antigen of Type II Group B Streptococcus", The Journal of Biological Chemistry, vol. 258:1793-1798. |
Jennings, et al., Biochemistry, 20(16):4511-4518, 1981. |
Kasper, et al. (1983) "Immunochemical Analysis and Immunogenicity of the Type II Group B Streptococcal Capsular Polysaccharide", J. Clin. Invest. vol. 72:260-269. |
Lagergard, et al., "Synthesis and Immunological Properties of Conjugates Composed of Group B Streptococcus Type III Capsular Polysaccharide Covalently Bound to Tetanus Toxoid", Infection and Immunity, Mar. 1990, vol. 58, No. 3, pp. 687-694. |
Lerner, R.A., et al. "The Development of Synthetic Vaccines", The Biology of Immunologic Disease, Dixon, F.J., et al., eds., Sinauer Associates: Sunderland, MA, pp. 331-338, 1983. |
Madoff, et al. "Maternal Immunization of Mice with Group B Streptococcal Type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple stereotypes", J. Clin. Invest., vol. 94, pp. 286-292, Jul. 1994. |
Madoff, L.C., et al. "Protection of Neonatal Mice from Group B Streptococcal Infection by Maternal Immunization with Beta C Protein", Infect. Immun., vol. 60, No. 12, pp. 4989-4994, Dec. 1992. |
Paoletti (1992) "Effects of Chain Length on the Immunogenicity in Rabbits of Group B Streptococcus Type III Oligosaccharride--Tetanus Toxoid Conjugate", J. Clin. Invest. 89:203-209. |
Paoletti (1992) "Group B Streptoccus Type II Polysaccharride--Tetanus Toxoid Conjugate Vaccine" Infection and Immunity, vol. 60:4009-4014. |
Paoletti, L.C., et al. "Group B Streptococcus Type III Glycoconjugate Vaccines", Trends in Glycosci. Glycotech., vol. 4, No. 17, pp. 269-278, May 1992. |
Paoletti, et al., "Immunogenicity of Group B Streptococcus Type III Polysaccharide-tetanus Vaccine in Baboons", Infection and Immunity, vol. 64, No. 2, pp. 677-679, Feb. 1996. |
Paoletti, et al. (1990) "An Oligosaccharide-Tetanus Toxoid Conjugate Vaccine against Type III Group B Streptococcus", The Journal of Biological Chemsitry, vol. 265:18278-18283. |
Pappenheimer, et al. (1972) "An Immunological Study of the Diptheria Toxin Molecule", Immunochemistry, vol. 9, pp. 891-906. |
Reuter et al., Glycoconjugate J. 6:35-44, 1989. |
Rodewald, et al. (1992) "Neonatal Mouse Model of Group B Streptococcal Infection", The Journal of Infectious Diseases, vol. 166:635-9. |
Roy, et al. "Efficient Synthesis of .alpha.(2-8)-Linked N-Acetyl and N-Glycolylyneuraminic Acid Disaccharides from Colominic Acid", Journal of Glycoconjugate, vol. 7, 1990, pp. 3-12. |
Ward et al., "Haemophilus Influenza Vaccines" in Vaccines, Plotkin et al eds. W.B. Saunders Co., Philadelphia, 1988 p. 300-330. |
Wessels, et al., "Immunogenicity and Protective Activity in Animals of a Type V Group B Streptococcal Polysaccharide-Tetanus Toxoid Conjugate Vaccine", The Journal of Infectious Diseases, vol. 171, 1995, pp. 879-884. |
Wessels, et al. "Structure and Immunochemistry of an Oligosaccharide Repeating Unit of the Capsular Polysaccharide of Type III Group B Streptococcus", The Journal of Biological Chemistry, vol. 262, No. 17, Jun. 15, 1987, pp. 8262-8267. |
Wessels et al., J. Biol. Chem. 266(11): 6714-6719, 1991. |
Wessels, et al., (1989) "Isolation and Characterization of Type IV Group B Streptococcus Capsular Polysaccharide" Infection and Immunity vol. 57, No. 4:1089-1904. |
Wessels, et al., J. Clin. Invest. 86:1428-1433, 1990. |
Wilkinson, H.W., et al. "Type-Specific Antigens of Group B Type Ic Streptococci", Infect. Immun., vol. 4, No. 5, pp. 596-604, Nov. 1971. |